Tumor mutation burden (TMB) and colorectal cancer.
What is tumor mutation burden (TMB)?
Tumor mutation burden (TMB) is a measure of the number of mutations carried by tumor cells. Tumors with many mutations have a high mutation burden (high TMB).
Many tumors with a high TMB (equal to or greater than 10) also have the biomarker MSI-H.
In MSI-H tumors, the somatic mutation occurs in one of the DNA mismatch repair genes that also results in MSI-H. These mutations can be passed along to new tumor cells during cell division. A small percentage of tumors with TMB also have the biomarker MSS.
What happens if I have a high TMB?
Knowing the TMB score of a tumor may help predict how well it will respond to immunotherapies.
This can help you and your doctor find the right treatment plan for you.
Other biomarkers
UGT1A1 BiomarkerTop resources
Does it matter where your colon cancer is located?
Understanding colon cancer sidedness is one more tool to help patients ask the right questions and advocate for the most effective treatment plan.
Bringing biomarker testing within reach: CLEAR for CRC to empower patients from day one
Biomarker testing can guide colorectal cancer treatment and improve outcomes. Learn how CLEAR for CRC is helping patients access this critical tool.
John E.: Biomarker testing uncovered a pivotal treatment option
After a grim prognosis, biomarker testing revealed a targeted treatment option for John E. Learn how knowing your biomarkers can change what’s possible.